bioMerieux, Inc. Opens a Subsidiary in the Middle East, Continuing its International Growth

MARCY L'ETOILE, France--(BUSINESS WIRE)--Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, announces the opening of a subsidiary in the United Arab Emirates. A hub for its operations in the Middle East, bioMérieux’s 39th subsidiary will be based in Dubai.
MORE ON THIS TOPIC